Long-Term Use of MS Drug Seems Safe
Preliminary Results Are in for 16-Year Follow-Up of Betaseron Study
"While it is premature to draw firm conclusions from preliminary data, I
am particularly struck by the mortality trend among patients in the placebo arm
appearing to be threefold different than that of patients receiving
Betaseron," says researcher Barry Arnason, MD, in a news release.
"The reasons for this difference are unknown right now, but hopefully,
we will get a clearer understanding of why this difference occurred when the
study is completed and the data analyzed more thoroughly," continues
Arnason, who works at the University of Chicago's neurology department.
The full report will include data on functions such as memory, attention,
and reasoning, says Ebers.
The follow-up data didn't include side effects. According to Berlex,
possible side effects include decrease in infection-fighting white blood cells,
injection site reaction, weakness, flu-like symptoms, headache, and pain.
Caution should be used with depressed patients, says Berlex. Also, the drug
company recommends rotating the injection sites, noting that injection site
necrosis has been reported in 5% of patients in trials.
Women should be warned about potential risks of using the drug while
pregnant, and cases of a rare but potentially life-threatening allergic
reaction have also been reported, says Berlex.